Publications by authors named "Jeffrey M Field"

Claim this Profile
P
p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs.
Jamie L Grit, Lauren E McGee, Elizabeth A Tovar, Curt J Essenburg, Emily Wolfrum, Jeffrey M Field

Oncogene· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Kinetics and (Dys)kinetics of Cancer Chronotherapy.
Jeffrey M Field, Amita Sehgal

Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian Rhythms, Disease and Chronotherapy.
Yool Lee, Jeffrey M Field, Amita Sehgal

J Biol Rhythms· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and Development of Therapeutics for COVID-19.
Halie M Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J Lee, Anna Ada Dattoli, Jeffrey M Field

mSystems· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and Development of Therapeutics for COVID-19.
Halie M Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J Lee, Anna Ada Dattoli, Jeffrey M Field

ArXiv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle.
Yool Lee, Shi Yi Fong, Joy Shon, Shirley L Zhang, Rebekah Brooks, Jeffrey M Field

Sci Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment.
Yool Lee, Nicholas F Lahens, Shirley Zhang, Joseph Bedont, Jeffrey M Field

PLoS Biol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis